The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing venous thromboembolism risk in HR+/HER2- breast cancer patients receiving CDK4/6 inhibitors: Insights from real-world data in the Middle East.
 
Nada Alsuhebany
No Relationships to Disclose
 
Ahmed Alanazi
No Relationships to Disclose
 
Mohammed Alzahrani
No Relationships to Disclose
 
Saleh Alyousef
No Relationships to Disclose
 
Bander Aldawish
No Relationships to Disclose
 
Sultan Aljardan
No Relationships to Disclose
 
Rawan Abu Alnasr
No Relationships to Disclose
 
Ibtihal Althumali
No Relationships to Disclose
 
Maha AlDoughaim
No Relationships to Disclose
 
Lama Alfehaid
No Relationships to Disclose
 
Sadal Refae
Honoraria - AstraZeneca/Daiichi Sankyo
Consulting or Advisory Role - Astrazeneca; Novartis
Speakers' Bureau - AstraZeneca/Daiichi Sankyo
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Hatoon Bakhribah
No Relationships to Disclose
 
Nafisa Abdelhafiez
Honoraria - AstraZeneca/Daiichi Sankyo
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Novartis
Speakers' Bureau - AstraZeneca/Daiichi Sankyo
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Novartis
 
Tariq Alqahtani
Stock and Other Ownership Interests - Abbvie; Johnson & Johnson; Merck; Reglagene
Honoraria - Reglagene
Consulting or Advisory Role - Reglagene; SPIMACO